Market Snapshot

BSE Sensex: 84478.67 0.01%
BSE 500: 37354.83 -0.08%
BSE 200: 11739.05 -0.04%
BSE 100: 27126.25 -0.02%
BSE MidCap: 47199.03 -0.34%
BSE SmallCap: 53096.27 -0.30%
BSE BANKEX: 65444.71 0.13%
BSE IT: 35829.11 -0.56%
Nifty 50: 25879.15 0.01%
Nifty 500: 23816 -0.09%
Nifty 200: 14460.55 -0.05%
Nifty 100: 26505.6 0.02%
Nifty Midcap 100: 60692.05 -0.35%
Nifty Small 100: 18183.65 -0.37%
Nifty IT: 36679.45 -0.48%
Nifty PSU Bank: 8303.05 -0.68%

News:

Eicher Motors Q2 PAT climbs 24...
Hariom Pipe Industries tumbles...
Infibeam Avenues spurts after ...
K&R Rail Engineering slumps af...
Marine Electricals rises as ne...

Divis Laboratories Ltd Share Price – NSE / BSE
Pharmaceuticals, Mid Cap

Invest

13 Nov 2025 | 04:14 PM

6,593.50

73.50 (1.13%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

14.67%

Return (1Y)

Beaten Nifty Pharma by 10.64%
More Volatile

1.71%

Standard Deviation (1Y)

Higher than Nifty Pharma by 0.67%
Not so consistent

6/12

Months

underperformed Nifty Pharma
AxisDirect View

No View

52 Week High-Low

7,072

4,955

News & Announcements

Divi's Laboratories consolidated net profit rises 35.10% in the September 2025 quarter
7 days ago

Divi's Laboratories consolidated net profit rises 35.10% in the September 2025 quarter

07 - Nov - 2025 12:00 | 7 days ago

Net profit of Divi's Laboratories rose 35.10% to Rs 689.00 crore in the quarter ended September 2025 as against Rs 510.00 crore during the previous quarter ended September 2024. Sales rose 16.12% to Rs 2715.00 crore in the quarter ended September 2025 as against Rs 2338.00 crore during the previous quarter ended September 2024.

Particulars Quarter Ended
Sep. 2025 Sep. 2024 % Var.

Sales 2715.00 2338.00 16

OPM % 32.71 30.62 -

PBDT 1025.00 821.00 25

PBT 912.00 722.00 26

NP 689.00 510.00 35

Powered by Capital Market - Live News
Divi's Laboratories standalone net profit rises 34.36% in the September 2025 quarter
7 days ago

Divi's Laboratories standalone net profit rises 34.36% in the September 2025 quarter

07 - Nov - 2025 12:00 | 7 days ago

Net profit of Divi's Laboratories rose 34.36% to Rs 696.00 crore in the quarter ended September 2025 as against Rs 518.00 crore during the previous quarter ended September 2024. Sales rose 15.55% to Rs 2660.00 crore in the quarter ended September 2025 as against Rs 2302.00 crore during the previous quarter ended September 2024.

Particulars Quarter Ended
Sep. 2025 Sep. 2024 % Var.

Sales 2660.00 2302.00 16

OPM % 33.65 31.67 -

PBDT 1033.00 833.00 24

PBT 920.00 735.00 25

NP 696.00 518.00 34

Powered by Capital Market - Live News
Divis Laboratories to announce Quarterly Result
17 days ago

Divis Laboratories to announce Quarterly Result

28 - Oct - 2025 12:00 | 17 days ago

Divis Laboratories will hold a meeting of the Board of Directors of the Company on 7 November 2025.
Powered by Capital Market - Live News
Divis Laboratories Ltd soars 1.53%, up for fifth straight session
32 days ago

Divis Laboratories Ltd soars 1.53%, up for fifth straight session

13 - Oct - 2025 12:00 | 32 days ago

Divis Laboratories Ltd is up for a fifth straight session today. The stock is quoting at Rs 6573.5, up 1.53% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.31% on the day, quoting at 25205.75. The Sensex is at 82205.85, down 0.36%. Divis Laboratories Ltd has gained around 8.53% in last one month.
Meanwhile, Nifty Pharma index of which Divis Laboratories Ltd is a constituent, has gained around 0.11% in last one month and is currently quoting at 22218.25, down 0.2% on the day. The volume in the stock stood at 6.63 lakh shares today, compared to the daily average of 5.25 lakh shares in last one month.
The benchmark October futures contract for the stock is quoting at Rs 6588, up 1.38% on the day. Divis Laboratories Ltd is up 5.77% in last one year as compared to a 0.31% jump in NIFTY and a 6.36% jump in the Nifty Pharma index.
The PE of the stock is 73.62 based on TTM earnings ending June 25.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

Divis Laboratories Ltd is trading very close to its All time High
Divis Laboratories Ltd is trading very close to its 52 Week High
MF shareholding in Divis Laboratories Ltd has increased by 5.08% since past 3 Months
GovT shareholding in Divis Laboratories Ltd has increased by 55.56% since past 3 Months

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	2715.00	2338.00	16
OPM %	32.71	30.62	-
PBDT	1025.00	821.00	25
PBT	912.00	722.00	26
NP	689.00	510.00	35

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	2660.00	2302.00	16
OPM %	33.65	31.67	-
PBDT	1033.00	833.00	24
PBT	920.00	735.00	25
NP	696.00	518.00	34

General Notifications

My Notifications

Research Notifications

Divis Laboratories Ltd Share Price – NSE / BSE Pharmaceuticals, Mid Cap

6,593.50 73.50 (1.13%)

News & Announcements

Price vs Volume

Stock Trivia

Divis Laboratories Ltd Share Price – NSE / BSE
Pharmaceuticals, Mid Cap

6,593.50

73.50 (1.13%)